BridgeMD
New treatment option for Heart Failure
Official title Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
ClinicalTrials.gov ID: NCT07263035
What this study is testing
What is Furosemide intravenous solution?
Furosemide intravenous solution is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for heart failure.
Also referred to as Lasix.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when treating patients hospitalized with acute heart failure when compared to lower urine sodium target and standard of care. The main questions it aims to answer are: 1.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- The study will target adults 18 years of age or older admitted to Lakeland Regional Medical Center who:
- Have a primary diagnosis of acute decompensated heart failure, and
- Have at least one of the following signs of hypervolemia:
- Bilateral lower extremity pitting edema
- Jugular venous distension
You likely can't join if
- Exclusion criteria include:
- Admission to the intensive care unit
- Presence of ST-elevated myocardial infarction
- Presence of type 1 non-ST elevated myocardial infarction
- Dyspnea primarily due to non-cardiac cause as judged by the emergency medicine physician or admitting physician
- Use of supplemental oxygen totaling at least 3 L per minute or greater at baseline
See the full eligibility criteria
- The study will target adults 18 years of age or older admitted to Lakeland Regional Medical Center who:
- Have a primary diagnosis of acute decompensated heart failure, and
- Have at least one of the following signs of hypervolemia:
- Bilateral lower extremity pitting edema
- Jugular venous distension
- Hepatojugular reflex
- Crackles on pulmonary exam, or
- Chest x-ray demonstrating pulmonary edema or pleural effusions
- Exclusion criteria include:
- Admission to the intensive care unit
- Presence of ST-elevated myocardial infarction
- Presence of type 1 non-ST elevated myocardial infarction
- Dyspnea primarily due to non-cardiac cause as judged by the emergency medicine physician or admitting physician
- Use of supplemental oxygen totaling at least 3 L per minute or greater at baseline
- Anuria
- End-stage renal disease per KDIGO criteria
- Dialysis use
The study team makes the final eligibility decision.
Where it's taking place
- Lakeland, Florida, United States
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lakeland, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.